Table 3.
Postoperative features | |
---|---|
Postoperative complications, n. (%) | 166 (8.5%) |
Surgical complications, n. (%) Clavien 1 surgical complications, n. Clavien 2 surgical complications, n. Clavien 3 surgical complications, n. Clavien 4 surgical complications, n. Clavien 5 surgical complications, n. |
77 (3.9%) 26 32 18 0 1 |
Medical complications, n. (%) Fever, n. UTI, n. Laboratory confirmed COVID-19 infections Acute renal failure, n. Respiratory complications, n. Vascular complications, n. Gastrointestinal disorders, n. Cardiologic complications, n. Metabolic disorders Delirium, n. |
89 (4.6%) 26 12 10 9 8 7 6 6 3 2 |
Length of stay (days), median (IQR) | 3 (1-5) |
Follow-up | |
Rehospitalization, n (%) | 28 (1.4%) |
Time to rehospitalization (days), median (IQR) | 11 (IQR 6–19) |
Fever in the 30 days following discharge, n (%) | 101 (5.2%) |
Respiratory symptoms in the 30 days following discharge, n (%) | 60 (3.1%) |
Confirmed contact with people presenting respiratory symptoms | 68 (3.5%) |
Confirmed contact with people infected with COVID-19 | 21 (1.1%) |
Nasopharyngeal swab in the 30 days following discharge, n (%) Not performed Negative Positive |
1888 (97.2%) 49 (2.5%) 6 (0.3%) |
Overall mortality, n (%) | 13 (0.7%) |
n – number; UTI – urinary tract infection; IQR – interquartile range